BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 38529533)

  • 21. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of the GABAergic System in Diseases of the Central Nervous System.
    Zhang W; Xiong BR; Zhang LQ; Huang X; Yuan X; Tian YK; Tian XB
    Neuroscience; 2021 Aug; 470():88-99. PubMed ID: 34242730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of brain structural connectivity in progression of Parkinson's disease: A connectome-wide network analysis.
    Yang Y; Ye C; Sun J; Liang L; Lv H; Gao L; Fang J; Ma T; Wu T
    Neuroimage Clin; 2021; 31():102715. PubMed ID: 34130192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Noncoding RNA SNHG1 Knockdown Ameliorates Apoptosis, Oxidative Stress and Inflammation in Models of Parkinson's Disease by Inhibiting the miR-125b-5p/MAPK1 Axis.
    Xiao X; Tan Z; Jia M; Zhou X; Wu K; Ding Y; Li W
    Neuropsychiatr Dis Treat; 2021; 17():1153-1163. PubMed ID: 33911864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease.
    Bloem BR; Okun MS; Klein C
    Lancet; 2021 Jun; 397(10291):2284-2303. PubMed ID: 33848468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical structural differences in major depressive disorder correlate with cell type-specific transcriptional signatures.
    Li J; Seidlitz J; Suckling J; Fan F; Ji GJ; Meng Y; Yang S; Wang K; Qiu J; Chen H; Liao W
    Nat Commun; 2021 Mar; 12(1):1647. PubMed ID: 33712584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease.
    Thomas GEC; Zarkali A; Ryten M; Shmueli K; Gil-Martinez AL; Leyland LA; McColgan P; Acosta-Cabronero J; Lees AJ; Weil RS
    Brain; 2021 Jul; 144(6):1787-1798. PubMed ID: 33704443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The default mode network and cognition in Parkinson's disease: A multimodal resting-state network approach.
    Ruppert MC; Greuel A; Freigang J; Tahmasian M; Maier F; Hammes J; van Eimeren T; Timmermann L; Tittgemeyer M; Drzezga A; Eggers C
    Hum Brain Mapp; 2021 Jun; 42(8):2623-2641. PubMed ID: 33638213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dementia risk in Parkinson's disease is associated with interhemispheric connectivity loss and determined by regional gene expression.
    Zarkali A; McColgan P; Ryten M; Reynolds RH; Leyland LA; Lees AJ; Rees G; Weil RS
    Neuroimage Clin; 2020; 28():102470. PubMed ID: 33395965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation.
    Kline EM; Houser MC; Herrick MK; Seibler P; Klein C; West A; Tansey MG
    Mov Disord; 2021 Jan; 36(1):25-36. PubMed ID: 33314312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genes associated with gray matter volume alterations in schizophrenia.
    Ji Y; Zhang X; Wang Z; Qin W; Liu H; Xue K; Tang J; Xu Q; Zhu D; Liu F; Yu C
    Neuroimage; 2021 Jan; 225():117526. PubMed ID: 33147509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local dynamic spontaneous brain activity changes in first-episode, treatment-naïve patients with major depressive disorder and their associated gene expression profiles.
    Xue K; Liang S; Yang B; Zhu D; Xie Y; Qin W; Liu F; Zhang Y; Yu C
    Psychol Med; 2022 Aug; 52(11):2052-2061. PubMed ID: 33121546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders.
    Seidlitz J; Nadig A; Liu S; Bethlehem RAI; Vértes PE; Morgan SE; Váša F; Romero-Garcia R; Lalonde FM; Clasen LS; Blumenthal JD; Paquola C; Bernhardt B; Wagstyl K; Polioudakis D; de la Torre-Ubieta L; Geschwind DH; Han JC; Lee NR; Murphy DG; Bullmore ET; Raznahan A
    Nat Commun; 2020 Jul; 11(1):3358. PubMed ID: 32620757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease.
    Piras IS; Bleul C; Schrauwen I; Talboom J; Llaci L; De Both MD; Naymik MA; Halliday G; Bettencourt C; Holton JL; Serrano GE; Sue LI; Beach TG; Stefanova N; Huentelman MJ
    Acta Neuropathol Commun; 2020 Jun; 8(1):76. PubMed ID: 32493431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomic signatures of brain regional vulnerability to Parkinson's disease.
    Keo A; Mahfouz A; Ingrassia AMT; Meneboo JP; Villenet C; Mutez E; Comptdaer T; Lelieveldt BPF; Figeac M; Chartier-Harlin MC; van de Berg WDJ; van Hilten JJ; Reinders MJT
    Commun Biol; 2020 Mar; 3(1):101. PubMed ID: 32139796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizotypy-Related Magnetization of Cortex in Healthy Adolescence Is Colocated With Expression of Schizophrenia-Related Genes.
    Romero-Garcia R; Seidlitz J; Whitaker KJ; Morgan SE; Fonagy P; Dolan RJ; Jones PB; Goodyer IM; Suckling J; ; Vértes PE; Bullmore ET
    Biol Psychiatry; 2020 Aug; 88(3):248-259. PubMed ID: 32029217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local vulnerability and global connectivity jointly shape neurodegenerative disease propagation.
    Zheng YQ; Zhang Y; Yau Y; Zeighami Y; Larcher K; Misic B; Dagher A
    PLoS Biol; 2019 Nov; 17(11):e3000495. PubMed ID: 31751329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease.
    Murueta-Goyena A; Andikoetxea A; Gómez-Esteban JC; Gabilondo I
    Front Pharmacol; 2019; 10():1294. PubMed ID: 31736763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gray Matter Changes in Parkinson's and Alzheimer's Disease and Relation to Cognition.
    Krajcovicova L; Klobusiakova P; Rektorova I
    Curr Neurol Neurosci Rep; 2019 Nov; 19(11):85. PubMed ID: 31720859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
    Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; ; ;
    Lancet Neurol; 2019 Dec; 18(12):1091-1102. PubMed ID: 31701892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.